Clinical xenotransplantation: Past, present and future

Annals of the Royal College of Surgeons of England

Volumn 79, Issue 1, 1997, Pages 13-19

  Taniguchi, Shigeki ^a   Cooper, David K C ^b,c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Concordant; Discordant; Genetic engineering; Natural antibodies; Xenotransplantation

Indexed keywords

BABOON; CHIMPANZEE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; ORGAN DONOR; ORGAN TRANSPLANTATION; RECIPIENT; REVIEW; SWINE; XENOTRANSPLANTATION;

ANIMALS; GENETIC ENGINEERING; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 0031025604     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Cooper DKC. Xenografting: how great is the clinical need! Xeno 1993; 1: 25.
2. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
3. Rose AG, Cooper DKC, Human PA et al. Histopathology of hyperacute rejection of the heart - experimental and clinical observations in allografts and xenografts. J Heart Transplant 1991; 10: 223.
4. Reemtsma K, McCracken BH, Schlegel JU et al. Renal heterotransplantation in man. Ann Surg 1964; 160: 384.
5. Starzl TE, Marchioro TL, Peters GN et al. Renal heterotransplantation from baboon to man: experience with 6 cases. Transplantation 1964; 2: 752.
6. Hardy JD, Kurrus FE, Chavez CM et al. Heart transplantation in man: developmental studies and report of a case. JAMA 1964; 188: 1132.
7. Marion P. Les transplantations cardiaques et les transplantations hepatiques. Lyon Med 1969; 222: 585.
8. Barnard CN, Wolpowitz A, Losman JG. Heterotopic cardiac transplantation with a zenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass. S Afr Med J 1977; 52: 1035.
9. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321.
10. Starzl TE, Marchioro TL, Farts TD, McCardle MJ, Iwasaki Y. Avenues of future research in homotransplantation of the liver. Am J Surg 1966; 112: 391.
11. Starzl TE. Orthotopic heterotransplantation. Experience in Hepatic Transplantation. Philadelphia: W B Saunders, 1969: 408.
12. Giles GR, Boehmig HJ, Amemiya H et al. Clinical heterotransplantation of the liver. Transplant Proc 1970; 2: 506.
13. Starzl TE, Ishikawa M, Putnam CW et al. Progress in and deterents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974; 6: 129.
14. Cramer DV, Sher L, Makowka L. Liver xenotransplantation: clinical experience and future considerations. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 559.
15. Starzl TE, Fung JJ, Tzakis A et al. Baboon-to-human liver transplantation. Lancet 1993; 341: 65.
16. Starzl TE, Tzakis A, Fung JJ et al. Human liver transplantation. Xeno 1993; 1: 4.
17. Starzl TE, Tzakis A, Fung JJ et al. Prospects of clinical xenotransplantation. Transplant Proc 1994; 26: 1082.
18. Kawauchi M, Gundry SR, Alonso de Begona J et al. Prolonged survival of orthotopically transplanted heart xenografts in infant baboons. J Thorac Cardiovasc Surg 1993; 106: 779.
19. Mieles L, Ye Y, Luo Y et al. Auxiliary liver allografting and xenografting in the non-human primate. Transplantation 1995; 59: 1670.
20. Hume DM. Discussion of Reemtsma paper. Ann Surg 1964; 160: 384.
21. Van der Riet F de St J, Human PA, Cooper DKC et al. Virological implications of the use of primates in xenotransplantation. Transplant Proc 1987; 19: 4068.
22. Luo Y, Taniguchi S, Kobayashi T, Niekrasz M, Cooper DKC. Screening of baboons as potential liver donors for humans. Xenotransplantation 1995; 2: 244.
23. Michaels MG, McMichael JP, Barsky K et al. Screening donors for xenotransplantation: the potential for xenozoonoses. Transplantation 1994; 57: 1462.
24. Michaels MG, Simmons RL. Xenozoonoses: possible xenotransplant-associated infections. Xeno 1994; 2: 47.
25. Allan JS. Xenotransplantation at a crossroads: prevention versus progress. Nature Med 1996; 2: 18.
26. Platt JL, Bach FH. Mechanism of tissue injury in hyperacute xenograft rejection. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 69.
27. Makowka L, Wu GD, Huffman A et al. Immunohistopathologic lesions associated with the rejection of a pig-to-human liver xenograft. Transplant Proc 1994; 26: 1074.
28. Cooper DKC, Ye Y, Rolf LL Jr, Zuhdi N. The pig as potential organ donor for man. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 481.
29. Czaplicki J, Blonska B, Religa Z. The lack of hyperacute xenogeneic heart transplant rejection in a human. J Heart Lung Transplant 1992; 11: 393.
30. Makowka L, Cramer DV, Huffman A et al. The use of a pig liver xenograft for temporary support of a patient with fulminant hepatic failure. Transplantation 1995; 59: 1654.
31. Good AH, Cooper DKC, Malcolm AJ et al. Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
32. Cooper DKC, Good AH, Koren E et al. Identification of α-galactosyl and other carbohydrate epitopes that are bound by human anti-pig antibodies: relevance to discordant xenografting in man. Transpl Immunol 1993; 1: 198.
33. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
34. Bach FH, Platt J, Cooper DKC. Accommodation - the role of natural antibody and complement in discordant xenograft rejection. In: Cooper DKC et al., eds. Xenotransplantation. Heidelberg: Springer, 1991: 81.
35. Cooper DKC, Ye Y, Niekrasz M et al. Specific intravenous carbohydrate therapy - a new concept in inhibiting antibody-mediated rejection: experience with ABO-incompatible cardiac allografting in the baboon. Transplantation 1993; 56: 769.
36. Alexandre GPJ, Squifflet JP, De Bruyere M et al. Present experience in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
37. McCurry KR, Kooyman DL, Alvarado G et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
38. Fodor WL, Kroshus TJ, Rollins SA et al. Engineering transgenic pig organs to resist hyperacute rejection in pig-to-primate xenotransplantation. Presented to the Third International Congress for Xenotransplantation, Boston, 1995 (Abstract po-31).
39. White DJG, Braidley R, Dunning J et al. Hearts from pigs transgenic for human DAF are not hyperacutely rejected when xenografted to primates. Presented to the Third International Congress for Xenotransplantation, Boston, 1995 (Abstract p1-28).
40. Inverardi L, Samaja M, Marelli F, Bender JR, Pardi R. Cellular immune recognition of xenogeneic vascular endothelium. Transplant Proc 1992; 24: 459.
41. Leventhal JR, Dalmasso AP, Cromwell JW et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
42. Kobayashi T, Taniguchi S, Ye Y et al. Delayed xenograft rejection in C3-depleted discordant (pig-to-baboon) cardiac xenografts treated with cobra venom factor. Transplant Proc 1996; 28: 560.
43. Bach FH, Robson SC, Winkler H. Barriers to xenotransplantation. Nature Med 1995; 1: 869.
44. Cooper DKC, Koren E, Oriol R. Genetically-engineered pigs. Lancet 1993; 342: 682.
45. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IFC. Anti-pig IgM antibodies in human serum react predominantly with Gal (α1-3)Gal epitopes. Proc Natl Acad Sci U S A 1993; 90: 11391.
46. Galili U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 80.
47. Tearle RG, Tange MJ, Zannettino ZL et al. The α-1,3-galactosyltransferase knockout mouse: implications for xenotransplantation. Transplantation 1996; 15: 13.
48. Cooper DKC, Koren E, Oriol R. Oligosaccharides and discordant xenotransplantation. Immunol Rev 1994; 141: 31.
49. Sandrin MS, Fodor WL, Mouhtouris E et al. Enzymatic remodeling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med 1995; 1: 1261.
50. Ye Y, Niekrasz M, Kosanke S et al. The pig as a potential organ donor for man: a study of potentially transferable disease from donor pig to recipient man. Transplantation 1994; 57: 694.
51. Smith DM. Endogenous retroviruses in xenografts (Letter). N Engl J Med 1993; 328: 142.
52. Sanfilippo F. Effects of complement inhibitors on discordant rodent and pig-to-primate cardiac xenograft rejection. Presented to the Third International Congress for Xenotransplantation, Boston, 1995 (Abstract) p 1-26.
53. Alexandre GPJ, Gianello P, Latinne D et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, ed. Xenograft 25. Amsterdam: Elsevier, 1989: 259.
54. The Gallup Organization Inc. The American Public's Attitudes Toward Organ Donation and Transplantation. Conducted for the Partnership for Organ Donation, Boston, MA, 1993.
55. Institute of Biology. Response to the Advisory Group on the Ethics of Xenotransplantation of the Department of Health. London, 1996.
56. Nuffield Council on Bioethics. Animal-to-Human Transplants: the Ethics of Xenotransplantation. London, 1996.
57. Groth CG, Andersson A, Korsgren O et al. Transplantation of porcine fetal islet-like cell clusters into eight diabetic patients. Transplant Proc 1993; 25: 970.
58. Satake M, Kawagishi N, Rydberg L et al. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters. Main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1994; 1: 89.
59. Michler RE, Chen JM. Cardiac xenotransplantation: a therapy whose time has come. Xeno 1994; 2: 53.
60. Gundrey SR. Is it time for cardiac xenotransplantation (again)? Xeno 1994; 2: 60.
61. Ye Y, Luo Y, Kobayashi T et al. Secondary organ allografting after a primary 'bridging' xenotransplant. Transplantation 1995; 60: 19.
62. Abouna GM. Extracorporeal xenogeneic liver perfusion for the treatment of hepatic failure. In: Cooper DKC et al., eds. Xenotransplantation, 2nd Edition. Heidelberg: Springer (in press).
63. Dubernard JM, Bonneau M, Latour M. Heterografts in Primates. Villeurbanne: Fondation Merieux, 1974: 43.
64. Cooper DKC, Ye Y. Experience with clinical heart xenotransplantation. In: Cooper DKC et al., eds. Xenotransplantation, 1st Edition. Heidelberg: Springer, 1991: 541.